R&D cloud platform for life sciences teams to design, track, and analyze experiments.
| Industry | Biotechnology |
| Stage | Series F |
| IPO Status | Pre-IPO |
| Valuation | $6.1B |
| Total Funding | $260M |
| Headquarters | San Francisco, CA |
| CEO | Sajith Wickramasekara |
Benchling is valued at $6.1B as of November 2021.
Benchling is currently classified as pre-IPO. No S-1 has been publicly filed. Monitor TechStackIPO for the latest IPO status updates.
Benchling has raised $260M in total venture capital funding.
Benchling is a Biotechnology company. R&D cloud platform for life sciences teams to design, track, and analyze experiments.
Benchling scores 70/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.